© 2021 MJH Life Sciences™ , Dermatology Times and Multimedia Medical, LLC. All rights reserved.
Fujisawa Inc, released data recently that supports the safety and efficacy of Protopic (tacrolimus ointment) 0.03 percent concentration in children with mild to moderate atopic dermatitis.